- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x SBM: 2-[[(2~{S})-2-decanoyloxy-3-dodecanoyloxy-propoxy]-oxidanyl-phosphoryl]oxyethyl-trimethyl-azanium(Non-covalent)
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.2: 15 residues within 4Å:- Chain A: W.307, Y.308, M.319, K.322, F.323, F.356, A.363, T.367, L.370, F.523, I.526, I.529, A.532, N.533
- Chain C: V.562
9 PLIP interactions:8 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:F.323, A:F.356, A:A.363, A:L.370, A:F.523, A:I.526, C:V.562
- Hydrogen bonds: A:Y.308
- Salt bridges: A:K.322
Y01.4: 10 residues within 4Å:- Chain A: N.612, K.614, F.615, N.618, I.619
- Chain B: M.444, L.445, G.448, P.504, I.517
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:K.614, A:F.615, A:N.618, A:I.619, B:L.445, B:I.517
- Hydrogen bonds: A:K.614
Y01.6: 15 residues within 4Å:- Chain A: V.562
- Chain B: W.307, Y.308, M.319, K.322, F.323, F.356, A.363, T.367, L.370, F.523, I.526, I.529, A.532, N.533
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:F.323, B:F.356, B:A.363, B:L.370, B:F.523, B:I.526, A:V.562
- Hydrogen bonds: B:Y.308
- Salt bridges: B:K.322
Y01.8: 9 residues within 4Å:- Chain B: K.614, F.615, N.618, I.619
- Chain D: M.444, L.445, G.448, P.504, I.517
7 PLIP interactions:2 interactions with chain D, 5 interactions with chain B- Hydrophobic interactions: D:L.445, D:I.517, B:K.614, B:F.615, B:N.618, B:I.619
- Hydrogen bonds: B:K.614
Y01.10: 9 residues within 4Å:- Chain A: M.444, L.445, G.448, P.504, I.517
- Chain C: K.614, F.615, N.618, I.619
7 PLIP interactions:5 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:K.614, C:F.615, C:N.618, C:I.619, A:L.445, A:I.517
- Hydrogen bonds: C:K.614
Y01.12: 15 residues within 4Å:- Chain C: W.307, Y.308, M.319, K.322, F.323, F.356, A.363, T.367, L.370, F.523, I.526, I.529, A.532, N.533
- Chain D: V.562
9 PLIP interactions:8 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:F.323, C:F.356, C:A.363, C:L.370, C:F.523, C:I.526, D:V.562
- Hydrogen bonds: C:Y.308
- Salt bridges: C:K.322
Y01.14: 9 residues within 4Å:- Chain C: M.444, L.445, G.448, P.504, I.517
- Chain D: K.614, F.615, N.618, I.619
7 PLIP interactions:5 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:K.614, D:F.615, D:N.618, D:I.619, C:L.445, C:I.517
- Hydrogen bonds: D:K.614
Y01.16: 15 residues within 4Å:- Chain B: V.562
- Chain D: W.307, Y.308, M.319, K.322, F.323, F.356, A.363, T.367, L.370, F.523, I.526, I.529, A.532, N.533
9 PLIP interactions:8 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:F.323, D:F.356, D:A.363, D:L.370, D:F.523, D:I.526, B:V.562
- Hydrogen bonds: D:Y.308
- Salt bridges: D:K.322
- 4 x R0D: (5-chloro-1'H-spiro[indole-3,4'-piperidin]-1'-yl)[(2R)-2,3-dihydro-1,4-benzodioxin-2-yl]methanone(Non-covalent)
R0D.3: 10 residues within 4Å:- Chain A: N.618, Y.621, V.622, G.625
- Chain B: V.587, E.588, F.591, F.595, W.596
- Ligands: SBM.5
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:E.588, B:F.591, B:F.595
- Hydrogen bonds: B:E.588, A:G.625
R0D.7: 10 residues within 4Å:- Chain B: N.618, Y.621, V.622, G.625
- Chain D: V.587, E.588, F.591, F.595, W.596
- Ligands: SBM.15
5 PLIP interactions:4 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:E.588, D:F.591, D:F.595
- Hydrogen bonds: D:E.588, B:G.625
R0D.9: 10 residues within 4Å:- Chain A: V.587, E.588, F.591, F.595, W.596
- Chain C: N.618, Y.621, V.622, G.625
- Ligands: SBM.1
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:E.588, A:F.591, A:F.595
- Hydrogen bonds: A:E.588, C:G.625
R0D.13: 10 residues within 4Å:- Chain C: V.587, E.588, F.591, F.595, W.596
- Chain D: N.618, Y.621, V.622, G.625
- Ligands: SBM.11
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:E.588, C:F.591, C:F.595
- Hydrogen bonds: C:E.588, D:G.625
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bai, Y. et al., Structural basis for pharmacological modulation of the TRPC6 channel. Elife (2020)
- Release Date
- 2020-03-18
- Peptides
- Short transient receptor potential channel 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x SBM: 2-[[(2~{S})-2-decanoyloxy-3-dodecanoyloxy-propoxy]-oxidanyl-phosphoryl]oxyethyl-trimethyl-azanium(Non-covalent)
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x R0D: (5-chloro-1'H-spiro[indole-3,4'-piperidin]-1'-yl)[(2R)-2,3-dihydro-1,4-benzodioxin-2-yl]methanone(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bai, Y. et al., Structural basis for pharmacological modulation of the TRPC6 channel. Elife (2020)
- Release Date
- 2020-03-18
- Peptides
- Short transient receptor potential channel 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
BD
C - Membrane
-
We predict this structure to be a membrane protein.